JPRN-UMIN000047650已完成未知
Prescription of Direct Oral Anticoagulant Affects Activated Clotting Time During Percutaneous Coronary Intervention and Bleeding Events - Prescription of Direct Oral Anticoagulant Affects Activated Clotting Time During Percutaneous Coronary Intervention and Bleeding Events
Tokyo women medical university0 个研究点目标入组 246 人开始时间: 2022年5月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 246
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients receiving warfarin at the time of percutaneous coronary intervention (PCI) and patients whose activated clotting time was not measured at the time of PCI initiation were excluded.
研究者
相似试验
招募中
不适用
Effects of treatment with oral anticoagulant associated with antibiotic therapy in Covid-19Covid-19B04.820.578.500.540.150RBR-7nzwkpgniversidade do Sul de Santa Catarina
已完成
不适用
Bleeding events of direct oral anti-coagulant for treatment of venous thromboembolism in advanced cancer patients.Venous thromboembolismJPRN-UMIN000020275Shizuoka Cancer Center147
招募中
不适用
The safety and efficacy of direct oral anticoagulants in patients with atrial fibrillation (AF)atrial fibrillationJPRN-UMIN000030673Tokyo Medical and Dental University1,000
招募中
4 期
Pharmacologic profile of direct oral anticoagulants in patients receiving Rituximab-CHOP chemotherapyewly diagnosed non-Hodgkin lymphoma,diffuse large B-cell lymphoma subtype,and who are planned to be treat with R-CHOP chemotherapy regimenTCTR20200824001Faculty of medicine Chiang Mai university26
招募中
不适用
Comparison between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Interventio10011082Chronic Coronary SyndromeCoronary Artery DiseaseNL-OMON51007Zuyderland Medisch Centrum1,270